Coherus Biosciences Inc (CHRS) Shares Soar Above 1-Year High
The stock of Coherus Biosciences Inc (NASDAQ: CHRS) has increased by 0.88 when compared to last closing price of 2.28. Despite this, the company has
The stock of Coherus Biosciences Inc (NASDAQ: CHRS) has increased by 0.88 when compared to last closing price of 2.28. Despite this, the company has
The 36-month beta value for CHRS is at 0.54. Analysts have varying views on the stock, with 6 analysts rating it as a “buy,” 2
Coherus Biosciences Inc (NASDAQ: CHRS)’s stock price has increased by 2.20 compared to its previous closing price of 2.27. However, the company has seen a
Additionally, the 36-month beta value for CHRS is 0.53. There are mixed opinions on the stock, with 6 analysts rating it as a “buy,” 2
The stock of Coherus Biosciences Inc (CHRS) has gone down by -9.42% for the week, with a 5.49% rise in the past month and a
The stock of Coherus Biosciences Inc (CHRS) has gone down by -3.12% for the week, with a -3.88% drop in the past month and a
and a 36-month beta value of 0.56. The public float for CHRS is 106.14M, and at present, short sellers hold a 26.50% of that float.
The stock price of Coherus Biosciences Inc (NASDAQ: CHRS) has dropped by -3.64 compared to previous close of 2.06. Despite this, the company has seen
© 2024, Fueled by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.